# Michael Weller

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-weller/

## Facts

| Field | Value |
| --- | --- |
| Citations | 169,601 |
| Field | Glioma Diagnosis and Treatment |
| h-index | 176 |
| i10-index | 1,111 |
| Last Known Institution | University of Zurich |
| OpenAlex ID | https://openalex.org/A5017177249 |
| ORCID iD | https://orcid.org/0000-0002-1748-174X |
| Works | 2,817 |

## Researcher papers

- [Immunotherapy response assessment in neuro-oncology: a report of the RANO working group](https://scholariq.org/papers/immunotherapy-response-assessment-in-neuro-oncology-a-report-of-the-rano-working/)
- [Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes](https://scholariq.org/papers/single-cell-mapping-of-human-brain-cancer-reveals-tumor-specific-instruction-of/)
- [High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial](https://scholariq.org/papers/high-dose-methotrexate-with-or-without-whole-brain-radiotherapy-for-primary-cns/)
- [Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/lomustine-temozolomide-combination-therapy-versus-standard-temozolomide-therapy/)
- [Leitlinien für Diagnostik und Therapie in der Neurologie](https://scholariq.org/papers/leitlinien-fur-diagnostik-und-therapie-in-der-neurologie/)
- [HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy](https://scholariq.org/papers/hla-ligand-atlas-a-benign-reference-of-hla-presented-peptides-to-improve-t-cell/)
- [INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma](https://scholariq.org/papers/intellance-2-eortc-1410-randomized-phase-ii-study-of-depatux-m-alone-and-with/)

## Researcher topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)
- [Meningioma and schwannoma management](https://scholariq.org/topics/meningioma-and-schwannoma-management/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Researcher university

- [University of Zurich](https://scholariq.org/institutions/university-of-zurich/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.